Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension

Clinical trial NCT02603809 · COMPLETED

Trial details

NCT number: NCT02603809
Sponsor: Idorsia Pharmaceuticals Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2015-12-14
Primary completion: 2017-02-28
Enrollment: 1659

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.